Summary
The deletion allele of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene has been suggested to be an independent risk factor for myocardial infarction, particularly in subjects judged to be “low-risk” by the criteria of lipid status and body mass index. In a prospective, matched case-control study, we have investigated the role of this polymorphism as a risk factor for myocardial infarction in 173 newly-diagnosed British Caucasian non-insulin-dependent diabetic subjects taken from the United Kingdom Prospective Diabetes Study who subsequently developed myocardial infarction and 297 control subjects from the same study population matched for known cardiovascular risk factors including age at diagnosis of diabetes, gender, blood pressure, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglyceride and smoking habit. A trend towards increased risk conferred by homozygosity for the deletion allele was observed in cases (odds ratio 1.63, p=0.09). When the population was stratified according to the matched risk factors, the deletion allele was associated with myocardial infarction in those with low plasma low-density lipoprotein cholesterol (odds ratio 3.67, p=0.002), or low triglyceride (odds ratio 3.14, p=0.005). The strongest association of the deletion allele with myocardial infarction was observed in subjects with both low low-density lipoprotein cholesterol and low triglyceride levels (odds ratio 9.0, p<0.001). These results show that the deletion allele is a risk factor for myocardial infarction in non-insulin-dependent diabetic patients who have a favourable lipid profile.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- ACE:
-
angiotensin-converting enzyme
- MI:
-
myocardial infarction
- I/D polymorphism:
-
insertion/deletion polymorphism
- I allele:
-
insertion allele
- D allele:
-
deletion allele
- DD genotype:
-
homozygosity for the deletion allele
- UKPDS:
-
United Kingdom Prospective Diabetes Study
References
Cambien F, Alhenc-Gelas F, Herbeth B et al. (1988) Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy study. Am J Hum Genet 38: 228–234
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 14: 1343–1346
Tiret L, Rigat B, Visvikis S et al. (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme gene controls plasma ACE levels. Am J Hum Genet 51: 197–205
Cambien F, Poirier O, Lecerf L et al. (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641–644
Tiret L, Kee F, Poirier O et al. (1993) Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 341: 991–992
Evans AE, Poirier O, Kee F et al. (1994) Polymorphisms of the angiotensin-converting enzyme gene in subjects who die from coronary heart disease. Quart J Med 87: 211–214
Ruiz J, Blanche H, Cohen N (1994) Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91: 3662–3665
Bohn M, Berge KE, Bakken A, Erikssen J, Berg K (1993) Insertion/deletion polymorphism at the locus for angiotensinogen I-converting enzyme and myocardial infarction. Clin Genet 44: 292–297
UK Prospective Diabetes Study Group (1991) UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia 34: 877–890
Rigat B, Hubert C, Corvol P, Soubrier F (1992) PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20: 1433
Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevin NC (1994) ACE gene typing. Lancet 343: 851
Shanmugan V, Sell KW, Saha BK (1993) Mistyping ACE heterozygotes. PCR Methods Applications 3: 120–121
Powell JS, Clozel JP, Muller RKM et al. (1989) Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245: 186–188
Abert G, Ferrer P (1990) Effects of captopril on atherosclerosis in Cynomolgus monkeys. J Cardiovasc Pharmacol 15: S65-S72
Pfeffer MA, Braunwald E, Moye LA (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 327 (10): 669–677
The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327 (10): 685–691
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Keavney, B.D., Dudley, C.R.K., Stratton, I.M. et al. UK Prospective Diabetes Study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM. Diabetologia 38, 948–952 (1995). https://doi.org/10.1007/BF00400584
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400584